Skip to content

Portable Pves Study

An Accuracy Study to Assess the Performance of the Peritron+ in Measuring Vesical Pressure in Patients in Comparison With Standard Urodynamic Measurements

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02673944
Enrollment
10
Registered
2016-02-04
Start date
2016-01-31
Completion date
2016-03-31
Last updated
2016-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Urinary Tract Symptoms

Brief summary

A comparative study will be conducted and the patient will undergo a conventional urodynamic study. In order to successfully determine if the Peritron+ is capturing vesical pressure measurements consistent with conventional urodynamics the two sources of Pves will be collected concurrently.

Interventions

DEVICEPeritron+

Peritron+ will be connected to a standard urodynamic analyzer system to measure vesical pressure

Sponsors

Laborie Medical Technologies Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients normally indicated for urodynamic evaluation

Exclusion criteria

* Patients who suffer from bladder infections * Patients who suffer from strictures in the urethra

Design outcomes

Primary

MeasureTime frameDescription
Accurate Vesical PRessureDuring a routine urodynamic study (1 hr approx)To validate that the Peritron+ digital readings are identical to the urodynamic readings (+/- 3 cm H2O) in the sitting position.

Participant flow

Participants by arm

ArmCount
Peritron+
Patients will undergo a routine urodynamic evaluation, the Peritron+ will be used in conjunction with a water-based urodynamic catheter Peritron+: Peritron+ will be connected to a standard urodynamic analyzer system to measure vesical pressure
10
Total10

Baseline characteristics

CharacteristicPeritron+
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Sex: Female, Male
Female
10 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Accurate Vesical PRessure

To validate that the Peritron+ digital readings are identical to the urodynamic readings (+/- 3 cm H2O) in the sitting position.

Time frame: During a routine urodynamic study (1 hr approx)

ArmMeasureValue (MEAN)Dispersion
Peritron+Accurate Vesical PRessure18.56 cm H2OStandard Deviation 8.29
Standard Urodynamic AnalyzerAccurate Vesical PRessure17.45 cm H2OStandard Deviation 7.85

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026